$AYI

O'Shaughnessy Laura purchased $22K of AYI

O'Shaughnessy Laura purchased 73 shares of ACUITY INC. (DE) (AYI) at $302.32 on 2026-10-16.

Original reporting
SEC EDGAR · O'Shaughnessy Laura
Published Oct 20, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 8:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AYI
Neutral
high confidence
Mentioned
$AYI
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AYINeutralLow
01

Why it matters

The filing adds a new data point on insider sentiment but is unlikely to trigger immediate trading activity.

02

Market read

A modest insider purchase with limited market impact; primarily of interest to shareholders monitoring insider activity.

03

What to watch

The director's ownership now totals 3,184 shares, which could become a more significant stake if further purchases occur.

Relevance 4/10Novelty 4/10Timing: today

Background

Form 4 filings disclose insider transactions and are required by the SEC. Such disclosures are primary sources of insider activity.

Company-level read

Ticker impact

$AYINeutralHigh confidence
Context

Director Laura O'Shaughnessy bought 73 shares of Acuity Inc. for $22,069, disclosed in a Form 4 filing on 2026‑10‑20.

Expected impact

slight upward pressure as the market prices in insider buying

Evidence & confidence

The transaction size ($22K) is modest for a mid‑cap director and represents a tiny fraction of total shares outstanding.

Market effects

None; the filing does not affect the broader medical‑device sector.

None; the transaction is company‑specific.

Low; only relevant to investors in AYI.

Counterpoint

Even a small insider purchase could signal confidence and may precede a larger upside.

Key entities

  • Acuity Inc.

    Medical‑device manufacturer listed on NYSE under ticker AYI.

  • Laura O'Shaughnessy

    Director of Acuity Inc. who executed the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AYIHighAI 9/10

Acuity to acquire Parameter Technologies for $675 million

Acuity Inc. (AYI) agreed to acquire Parameter Technologies for $675M. Parameter, which provides data center monitoring solutions, expects $100M in 2027 sales with 40% EBITDA margins. Acuity will fund the deal with $500M in debt and cash, aiming to close in Q2 2027. The acquisition is expected to boost Acuity's earnings per share.